LogicBio Therapeutics: Q1 Earnings Insights


LogicBio Therapeutics LOGC reported its Q1 earnings results on Monday, May 16, 2022 at 08:30 AM.

Here's what investors need to know about the announcement.


LogicBio Therapeutics beat estimated earnings by 28.57%, reporting an EPS of $-0.2 versus an estimate of $-0.28.

Revenue was up $2.35 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.06 which was followed by a 2.94% drop in the share price the next day.

Here's a look at LogicBio Therapeutics's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.34 -0.30 -0.24 -0.15
EPS Actual -0.28 -0.31 -0.33 -0.32
Revenue Estimate 1.45M 5.45M 6.97M 10.45M
Revenue Actual 2.03M 2.12M 802.00K 461.00K

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for LogicBio Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: EarningsBZI-Recaps